# [Subject of care] **Category:** [Technical (archive)](https://discourse.openehr.org/c/technical-archive/156) **Created:** 2002-12-15 19:45 UTC **Views:** 3 **Replies:** 22 **URL:** https://discourse.openehr.org/t/subject-of-care/15696 --- ## Post #1 by @thomas.beale I am forwarding this to the list, since I think this is an important discussion\. Sam Heard said: Tom The donor is definitely anonymous in most settings\. The fetus can be part of the mother \- this is a bit like the local terminologies in archetypes \- we need a way of saying that the relationship is the only defining feature and there is no ID\. Cheers, Sam --- ## Post #2 by @aniket_Joshi Doesn't it depend on the legislation of individual country and religiuos belief?? Do we also apply the same rule to Blood Donors and solid organ donors\. ANIKET --- ## Post #3 by @system Dear All, Just a couple of use cases for the discussion: 1\. If prenatal diagnosis is being done by chorionic villus sampling \(CVS\) in a twin pregnancy \(which does happen\) then it is the placenta \- or rather the placentas \- which are sampled\. Each placenta has a DNA genotype matching that of the fetus attached to it \(ie not the mother\) as the placenta is an extension of the fetus\. If however the fetus is an extension of the mother, then are we really saying we like the idea that the placentas may have to appear as multiple "temporary" organs of the mother, which are different in every pregnancy, and which never share her total genotype? A likely outcome would be selective termination of one twin \(the affected one, on the basis of a molecular finding and either a makable or a confidently predictable clinical diagnosis\) leaving the unaffected one to go to term\. Thus a part of the mother is diagnosed clinically and molecularly, findings which are important for the mother later on, in that they'll trigger appropriate care next time around, but which \*must not\* be confused with her own clinical diagnoses or test results\. 2\. Bone marrow transplantation, where it may be necessary to distinguish that the post\-transplant patient may still have a haemoglobin variant, but a different one to the one they were treated for, and accordingly no disorder to go with it, but will still be genetically as they were before the treatment in every other organ\. Also the donor was most probably selected from the same family, so confidentiality may be slightly different\.\.\.? It seems to me that we can either organise our concepts to make this kind of record easier and more obvious, or we can begin to inbuild problems for later on \(eg if the fetus is part of the mother, having to explain to all our knowledge agents that this might not extend to genotypes, or if it does, then by chance rather than biological imperative etc\.\.\.\)\. In the event of one of two fetuses being affected, and one pregnancy being terminated, what is the result in the record to indicate the original number of conceptions, the fact that a genetic risk actually produced a fetus with a prospective problem, and the DNA and other data originated in the process of the testing of the CVS sample? It would be wrong, I feel, to treat the fetus' diagnosis as one of the mother, as confusion here could lead to all kinds of erroneous conclusions \(one fetus had sickle cell \-> mother \- who is actually just a carrier \- has sickle cell\.\.\.?\)\. Just some thoughts\! Yours, Matthew --- ## Post #4 by @Sam Matthew Great scenario's > 1\. If prenatal diagnosis is being done by chorionic villus sampling > \(CVS\) in a twin pregnancy \(which does happen\) then it is the placenta > \- or rather the placentas \- which are sampled\. Each placenta has a > DNA genotype matching that of the fetus attached to it \(ie not the > mother\) as the placenta is an extension of the fetus\. If however the > fetus is an extension of the mother, then are we really saying we > like the idea that the placentas may have to appear as multiple > "temporary" organs of the mother, which are different in every > pregnancy, and which never share her total genotype? A likely outcome > would be selective termination of one twin \(the affected one, on the > basis of a molecular finding and either a makable or a confidently > predictable clinical diagnosis\) leaving the unaffected one to go to > term\. Thus a part of the mother is diagnosed clinically and > molecularly, findings which are important for the mother later on, in > that they'll trigger appropriate care next time around, but which > \*must not\* be confused with her own clinical diagnoses or test > results\. This example is a very good one \- it shows that there is a need to identify the fetus over and above its relationship with the mother\. I have suggested that we use a local label for this \- could be LOCAL:Twin1\_2002\. \- the relationship for the information is FETUS\. The important thing here is that we have the idea of subject of care \- a unique identifier \(or self\) and the relationship\. The sampling is the taking of a histological sample of a body part \- the subject is the FETUS\. There will be a procedure record, a sample and a histological report \- all with the fetus as the subject of care for the data \- in a composition that is part of the mothers EHR\. It may be copied to the child's EHR in the future \- I have thought about the transform required to do this and it should be relatively easy if the relationship of the two records is stated first\. > 2\. Bone marrow transplantation, where it may be necessary to > distinguish that the post\-transplant patient may still have a > haemoglobin variant, but a different one to the one they were treated > for, and accordingly no disorder to go with it, but will still be > genetically as they were before the treatment in every other organ\. > Also the donor was most probably selected from the same family, so > confidentiality may be slightly different\.\.\.? Interesting \- who is the subject of care then? I guess this will be deduced from the data \- I do not think that we can say the origins of all the states in a person that arise following a donation \- at times it may be ambiguous \(graft v host\)\. We have considered 'donor' to be the relationship \- but the person may have a relationship with the person apart from this? I do not think that the subject of care needs to be the donor then \- it can be the family member as it is known who they are\. Interesting\! > It seems to me that we can either organise our concepts to make this > kind of record easier and more obvious, or we can begin to inbuild > problems for later on \(eg if the fetus is part of the mother, having > to explain to all our knowledge agents that this might not extend to > genotypes, or if it does, then by chance rather than biological > imperative etc\.\.\.\)\. In the event of one of two fetuses being > affected, and one pregnancy being terminated, what is the result in > the record to indicate the original number of conceptions, the fact > that a genetic risk actually produced a fetus with a prospective > problem, and the DNA and other data originated in the process of the > testing of the CVS sample? It would be wrong, I feel, to treat the > fetus' diagnosis as one of the mother, as confusion here could lead > to all kinds of erroneous conclusions \(one fetus had sickle cell \-> > mother \- who is actually just a carrier \- has sickle cell\.\.\.?\)\. I do believe that we have this covered \- the donor example is a bit of a mind bender but I think the subject of care and relationship provides the solution\. COmments? Cheers, Sam --- ## Post #5 by @system Hi, Yes nice, but \.\.\. Dealing with 80% of all 'normal' problems that can be encountered is difficult enough\. 'Give me a solution and I will find the problems, the scenario's that will brake the solution' The 20% of 'abnormal' problems can \(and will have to be\) dealt with later\. Gerard > Matthew > > Great scenario's > >> 1\. If prenatal diagnosis is being done by chorionic villus sampling >> \(CVS\) in a twin pregnancy \(which does happen\) then it is the placenta >> \- or rather the placentas \- which are sampled\. Each placenta has a >> DNA genotype matching that of the fetus attached to it \(ie not the >> mother\) as the placenta is an extension of the fetus\. If however the >> fetus is an extension of the mother, then are we really saying we >> like the idea that the placentas may have to appear as multiple >> "temporary" organs of the mother, which are different in every >> pregnancy, and which never share her total genotype? A likely outcome >> would be selective termination of one twin \(the affected one, on the >> basis of a molecular finding and either a makable or a confidently >> predictable clinical diagnosis\) leaving the unaffected one to go to >> term\. Thus a part of the mother is diagnosed clinically and >> molecularly, findings which are important for the mother later on, in >> that they'll trigger appropriate care next time around, but which >> \*must not\* be confused with her own clinical diagnoses or test >> results\. > > This example is a very good one \- it shows that there is a need to identify > the fetus over and above its relationship with the mother\. I have suggested > that we use a local label for this \- could be LOCAL:Twin1\_2002\. \- the > relationship for the information is FETUS\. The important thing here is that > we have the idea of subject of care \- a unique identifier \(or self\) and the > relationship\. > > The sampling is the taking of a histological sample of a body part \- the > subject is the FETUS\. There will be a procedure record, a sample and a > histological report \- all with the fetus as the subject of care for the > data \- in a composition that is part of the mothers EHR\. It may be copied to > the child's EHR in the future \- I have thought about the transform required > to do this and it should be relatively easy if the relationship of the two > records is stated first\. > >> 2\. Bone marrow transplantation, where it may be necessary to >> distinguish that the post\-transplant patient may still have a >> haemoglobin variant, but a different one to the one they were treated >> for, and accordingly no disorder to go with it, but will still be >> genetically as they were before the treatment in every other organ\. >> Also the donor was most probably selected from the same family, so >> confidentiality may be slightly different\.\.\.? > > Interesting \- who is the subject of care then? I guess this will be deduced > from the data \- I do not think that we can say the origins of all the states > in a person that arise following a donation \- at times it may be ambiguous > \(graft v host\)\. > > We have considered 'donor' to be the relationship \- but the person may have > a relationship with the person apart from this? I do not think that the > subject of care needs to be the donor then \- it can be the family member as > it is known who they are\. Interesting\! > >> It seems to me that we can either organise our concepts to make this >> kind of record easier and more obvious, or we can begin to inbuild >> problems for later on \(eg if the fetus is part of the mother, having >> to explain to all our knowledge agents that this might not extend to >> genotypes, or if it does, then by chance rather than biological >> imperative etc\.\.\.\)\. In the event of one of two fetuses being >> affected, and one pregnancy being terminated, what is the result in >> the record to indicate the original number of conceptions, the fact >> that a genetic risk actually produced a fetus with a prospective >> problem, and the DNA and other data originated in the process of the >> testing of the CVS sample? It would be wrong, I feel, to treat the >> fetus' diagnosis as one of the mother, as confusion here could lead >> to all kinds of erroneous conclusions \(one fetus had sickle cell \-> >> mother \- who is actually just a carrier \- has sickle cell\.\.\.?\)\. > > I do believe that we have this covered \- the donor example is a bit of a > mind bender but I think the subject of care and relationship provides the > solution\. > > COmments? > > Cheers, Sam > \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ > Dr Sam Heard > Ocean Informatics, openEHR > Co\-Chair, EHR\-SIG, HL7 > Chair EHR IT\-14\-2, Standards Australia > Hon\. Senior Research Fellow, UCL, London > > 105 Rapid Creek Rd > Rapid Creek NT 0810 > > Ph: \+61 417 838 808 > > sam\.heard@bigpond\.com > > www\.openEHR\.org > www\.HL7\.org > \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ > > \- > If you have any questions about using this list, > please send a message to d\.lloyd@openehr\.org \-\- <private> \-\- Gerard Freriks, arts Huigsloterdijk 378 2158 LR Buitenkaag The Netherlands \+31 252 544896 \+31 654 792800 --- ## Post #6 by @Eric_Browne1 Very pragmatic, but \.\.\. If dealing with the 20% of 'abnormal' problems later, means completely redesigning and reimplementing a solution, then your pragmatic approach may not be the best\. Designing and building a national or international EHR\-based healthcare system is like getting someone to the moon \- it is a complex and expensive exercise\. Better to pre\-empt the abnormal situations and build something that you hope will succeed, than to build a rocket that you know will fail\. eric --- ## Post #7 by @thomas.beale I think that the only systematic approach is to make a new EHR for each genetically distinct individual\. This means making an EHR for a foetus as soon as anything at all is to be measured about it, and also storing the link of this EHR to that of the mother\. If the foetus dies in utero or is aborted, then its EHR shows this properly as "death" jsut as it would be shown in a normal person's record\. As for situations where the individual's DNA distinctness is not totally clear like the bone marro transplant situation, I don't think that is a problem\. Observations can be made on genetically different material to the patient, in the patient's record, as long as these observations relate to the care of that patient\. E\.g\. blood tests, other tests made to a sibling for the sole purpose of doing a transplant into the patient \- should probably go into the patient's EHR\.\.\. But I do think we need to forget the idea that because a foetus is not really a person, it is not a possible subject of an EHR\. I think we have to work on genetic distinction and distinct organism \(whether called "human" or not\) instead\. thoughts? \- thomas Sam Heard wrote: >Matthew > >Great scenario's > >>1\. If prenatal diagnosis is being done by chorionic villus sampling >>\(CVS\) in a twin pregnancy \(which does happen\) then it is the placenta >>\- or rather the placentas \- which are sampled\. Each placenta has a >>DNA genotype matching that of the fetus attached to it \(ie not the >>mother\) as the placenta is an extension of the fetus\. If however the >>fetus is an extension of the mother, then are we really saying we >>like the idea that the placentas may have to appear as multiple >>"temporary" organs of the mother, which are different in every >>pregnancy, and which never share her total genotype? A likely outcome >>would be selective termination of one twin \(the affected one, on the >>basis of a molecular finding and either a makable or a confidently >>predictable clinical diagnosis\) leaving the unaffected one to go to >>term\. Thus a part of the mother is diagnosed clinically and >>molecularly, findings which are important for the mother later on, in >>that they'll trigger appropriate care next time around, but which >>\*must not\* be confused with her own clinical diagnoses or test >>results\. >> > >This example is a very good one \- it shows that there is a need to identify >the fetus over and above its relationship with the mother\. I have suggested >that we use a local label for this \- could be LOCAL:Twin1\_2002\. \- the >relationship for the information is FETUS\. The important thing here is that >we have the idea of subject of care \- a unique identifier \(or self\) and the >relationship\. > >The sampling is the taking of a histological sample of a body part \- the >subject is the FETUS\. There will be a procedure record, a sample and a >histological report \- all with the fetus as the subject of care for the >data \- in a composition that is part of the mothers EHR\. It may be copied to >the child's EHR in the future \- I have thought about the transform required >to do this and it should be relatively easy if the relationship of the two >records is stated first\. > >>2\. Bone marrow transplantation, where it may be necessary to >>distinguish that the post\-transplant patient may still have a >>haemoglobin variant, but a different one to the one they were treated >>for, and accordingly no disorder to go with it, but will still be >>genetically as they were before the treatment in every other organ\. >>Also the donor was most probably selected from the same family, so >>confidentiality may be slightly different\.\.\.? >> > >Interesting \- who is the subject of care then? I guess this will be deduced >from the data \- I do not think that we can say the origins of all the states >in a person that arise following a donation \- at times it may be ambiguous >\(graft v host\)\. > >We have considered 'donor' to be the relationship \- but the person may have >a relationship with the person apart from this? I do not think that the >subject of care needs to be the donor then \- it can be the family member as --- ## Post #8 by @Philippe_AMELINE1 Hi, > I think that the only systematic approach is to make a new EHR for each > genetically distinct individual\. This means making an EHR for a foetus > as soon as anything at all is to be measured about it, and also storing > the link of this EHR to that of the mother\. This is a very interesting issue for the Ligne de vie \(LdV\), but a challenge as well : the foetus LdV could be also seen as a window inside his mother's LdV during the in\-utero period of time\. Hard work, but we have to think to it early enough\. Philippe --- ## Post #9 by @Sam Tom This is not necessary or appropriate \- as Matthew has said \- placenta is both\! It is important that our solution allows information about another person to be in an EHR \- family history is a good example\. We will not link between peoples EHRs \- ever in my opinion\. Cheers, Sam --- ## Post #10 by @thomas.beale Sam Heard wrote: > Tom > > This is not necessary or appropriate \- as Matthew has said \- placenta is > both\! > don't see a problem\. If observatios are being made from the placenta to determine the health / viability of the foetus, then these are added to the record of the foetus\. Why not? > It is important that our solution allows information about another > person to be in an EHR \- family history is a good example\. We will not link > between peoples EHRs \- ever in my opinion\. > THis would be done in the demographic service \- not in the EHR\. It's just a family relationship link\. \- t --- ## Post #11 by @Eric_Browne1 Sam, I take Tom's position\. The issue is whether there is a one to one mapping between subject of care and an EHR\. > From a health perspective, a foetus can be considered as a subject of care in its own right\. A foetus is tightly coupled to a mother, but is sufficiently distinct for there to be a need for a separate EHR under certain circumstances\. The question is when do we spawn a new record? Under normal circumstances, this would probably occur at birth, partly since the foetus becomes a person under law, partly because it becomes an entity predominantly independent of the mother, partly because prior to birth there is rarely a need for information specifically regarding the foetus\. However, when the foetus does become a subject of care, i\.e\. measurements and interventions are undertaken specifically for the benefit of the foetus, there are good grounds for spawning a separate EHR\. Either approach requires a more complex EHR model\. But surely the raison d'etre of an EHR is to promote the care of a subject? Or is it being proposed for some other reason of which I am unaware? eric --- ## Post #12 by @thomas.beale Eric Browne wrote: > Sam, > > I take Tom's position\. The issue is whether there is a one to one > mapping between subject of care and an EHR\. > >> From a health perspective, a foetus can be considered as a subject of > > care in its own right\. > and I think it can certainly be considered a "subject of clinical Statements" even if one feels that making observations on a foetus is not "care"\.\.\. > A foetus is tightly coupled to a mother, but is sufficiently > distinct for there to be a need for a separate EHR under certain > circumstances\. The question is when do we spawn a new record? > Under normal circumstances, this would probably occur at birth, partly > since the foetus becomes a person under law, partly because it becomes > an entity predominantly independent of the mother, partly because prior > to birth there is rarely a need for information specifically regarding > the foetus\. > which is what I used to think, based on Sam's thinking, but having had this discussion, I have changed my mind\. As soon as the first observation is made of the foetus it should have its own EHR\. > However, when the foetus does become a subject of care, i\.e\. measurements > and interventions are undertaken specifically for the benefit of the > foetus, there are good grounds for spawning a separate EHR\. > > Either approach requires a more complex EHR model\. > I'm not sure what these are yet, but I guess I can see a few things that need to be sorted out: \- connection between mother and child \(can be done in the demogarphic server\) \- when there are twins \- when things go wrong, e\.g\. ectopic pregnancies > But surely the > raison d'etre of an EHR is to promote the care of a subject? Or is it > being proposed for some other reason of which I am unaware? > not as far as I know\! \- thomas --- ## Post #13 by @Philippe_AMELINE1 >> A foetus is tightly coupled to a mother, but is sufficiently >> distinct for there to be a need for a separate EHR under certain >> circumstances\. What do you call "certain circumstances" ; anyway, the follow up echographies during pregnancy belong to the future baby\. >> The question is when do we spawn a new record? >> Under normal circumstances, this would probably occur at birth, partly >> since the foetus becomes a person under law, partly because it becomes >> an entity predominantly independent of the mother, partly because prior >> to birth there is rarely a need for information specifically regarding >> the foetus\. > > which is what I used to think, based on Sam's thinking, but having had this discussion, I have changed my mind\. As soon as the first observation is made of the foetus it should have its own EHR\. I agree with that\. A solution coul be to open an EHR immediately \(first echography ?\) and have this EHR usable as a "time delimited window" inside the mother EHR\. The other solution \(more pragmatic\) would be to have the mother's pregnancy "Problem" \(just POMR way of labelling things\) being opened as a "before birth window" inside the baby record\. It is more pragmatic since the "system" you work on during pregnancy is the mother \(with extra "organs"\)\. I can't guess the legal issues\. Philippe --- ## Post #14 by @system Dear All, It might be useful for me to clarify why I proposed the CVS use case in the first place\. I saw Sam's assertion that "the fetus can be treated as part fo the mother", and that bothered me because while that's the legal state of affairs in many places, if implemented thoroughly it also means every woman is a genetic mosaic with different genotypes every time she's pregnant, which seems like a minefield to me \- do we really want to make it that hard? The placenta arises because it would appear not to be part of the fetus, and it's the mother who develops it, but it's actually the thing which is tested to establish a genotype for the fetus wihtout being invasive of it \(it replaced fetal blood sampling in the second trimester for that purpose\), so again the mosaic problem arises\. My main concern was to have a way of clearly determinig which genotype\(s \- some people are mosaics anyway\!\) are actually the mother's, which are the fetus' and which are neither in that like the placenta they simple vanish from the picture outside a given window\.\.\. The bone marrow case was more about seeing a bone marrow transplanted patient as a therapeutically created mosaic, but making sure that it could be recorded that this individual has in effect an unreliable blood genotype for extrapolating that to other organs \(antenatal care at least in the UK assumes that if you've sampled the blood you've sampled the individual\.\.\.\!\)\. It's also interesting because the donor is almost certainly a close relative \(so it's perhaps not the same kind of secret\) but is also probably alive \(ie the organ transplanted has not been "harvested" after a trauma\.\.\.\)\. Again it's a window, but this time open\-ended assumig graft versus host can be avoided\.\.\. I'm beginning to see a general question here, which would also cover prostheses \(just because the hip is made of titanium\.\.\.\) but more interestingly tumours which are "of" the organ in or at which they are located, but which are histologically and genetically different, are additional masses, and may also be "temporary" in that once detected they may be removed or suppressed/shrunk in some other way\.\.\. On the question of assigning identifiers, when the reason for the selective termination of one of twin pregnancies is a lab result and a prediction rather than something you could see visibly on ultrasound etc, does anyone know how obstetricians work out which the target fetus is? Normally in medicine such things seem to be done by laterality \(for kidneys, limbs, etc\.\) but I was under the impression that fetuses were too mobile to reliably do it that way\.\.\. Regardig new EHRs etc, might there be scope for mimicking what nature does \- a child EHR which for example must inherit its identifier context from its mother as it really can only be identified meaningfully by a qualifier of "this is the demographic person inside which it is located"\.\.\.? Yours, Matthew --- ## Post #15 by @thomas.beale Matthew Darlison wrote: > Regardig new EHRs etc, might there be scope for mimicking what nature does \- a child EHR which for example must inherit its identifier context from its mother as it really can only be identified meaningfully by a qualifier of "this is the demographic person inside which it is located"\.\.\.? > This could be solved in at least two ways\. 1\. In the demographic server, we create 2 PERSONs, and use a foetus archetype for one\. We put a mother/in utero PARTY\_RELATIONSHIP between them\. however, the in utero relationship as a clinical phenomenon is probably more important than the legal mother/child relationship, which is the kind of thing demographic systems are designed for \(this relationship does not change as long as both parties are alive, but the carrying/in utero physical relationship is fairly temporary\. 2\. In the EHR system we use an archetype for a persistent transaction in the foetus's EHR which indicates the "in utero" situation \(this would probably be the same archetype that carries other important clinical indicators, like "living", "deceased" etc\)\. In the mother's EHR there is also a "carrying child" indicator\. 2a\. THese could refer to distinct demographic entities found in the demographic server, if we think that the foetus should be given one\. If not \(and I agree that it might not be that useful, since there is no name, contact address etc \(other than the mother\) and the foetus is not "contactable" in any real way \- in fact it cannot act as a PARTY \(i\.e\. participate in anything\)\. So \- let's say that the foetus either has nothing in the demographic system, or else we introduce a special party called "unborn foetus" \(the same thing I suggest for "anonymous donor"\)\. Then the Foetus can have a demographic entity to which its EHR is attached, without the needless creation of "real" PARTYs with all their details, all initially meaningless for a foetus \(and probabl a newborn for quite some time\.\.\.\)\. The alternative which I imagine Sam would prefer is to make one or more transactions dedicated to the foetus in the mother's EHR and put them in their own "unborn child" folder or so\. These would then be moved out of the mother's EHR when the baby is born\. I think this would work ok, but it is kind of a special case, and we have to make sure all software understands it\. Maybe we could formalise this situation so that one EHR can "give birth" to another, which is implied by Matthew's words\. It sounds funny, but maybe it isn't \- why not \- there is nothing to stop us from defining a "give birth" operation on the interface of the EHR \(trekkies and unix\-heads will naturally insist that the operation be called "spawn", and who would I be to argue\.\.\.\.?\-\)\. The situation is not necessarily the same for anonymous donors, since no care is being given to them \- they don't need their own EHR \- the observations of the organs etc belong in the EHR or the recipient since it is about his/her care, not the donors\. For non\-anonymous donors, then of course an EHR is needed \- the health of both donor and recipient during kidney, bone marrow and other similar operations, and afterward is important jsut as in the normal situation of any individual\. I am happy to see this discussed further; in summary I suggest that the basic possibilities are : a \- create a new EHR as soon as a foetus has any observation done on it, link it to an "unborn baby" demographic entity b \- define the semantics of an EHR "being pregnant" with another nascent EHR, and a "give birth to EHR"/"spawn EHR" operation to be carried out when the real birth takes place\. \(The less fortunate outcomes for the foetus could also make sense, as long as they have operations defined for them, including "abort", "die naturally" etc\)\. Having thought of b\), and the possibility of one day seeing one EHR give birth to another, I am quite taken with the possibility\.\.\.\.however, it still creates the precedent that there are EHRs containing two \(or more\) subjects of care\. thoughts? \- thomas beale --- ## Post #16 by @Ignacio_Valdes On Thu, 19 Dec 2002 07:24:33 \+0930 > I think that the only systematic approach is to make a new EHR for each genetically distinct individual\. This means making an EHR for a foetus as soon as anything at all is to be measured about it, and also storing the link of this EHR to that of the mother\. But if you really want to think forwardly and cover all bases, what about clones? I'm being half facetious, but it makes for an interesting discussion\. --- ## Post #17 by @thomas.beale Ignacio Valdes wrote: > On Thu, 19 Dec 2002 07:24:33 \+0930 > >> I think that the only systematic approach is to make a new EHR for each genetically distinct individual\. This means making an EHR for a foetus as soon as anything at all is to be measured about it, and also storing the link of this EHR to that of the mother\. > > But if you really want to think forwardly and cover all bases, what about clones? I'm being half facetious, but it makes for an interesting discussion\. well, I would have laughed at that idea last year, but not now\.\.\. \- thomas beale --- ## Post #18 by @William_E_Hammond We actually dealt with this topic at Duke in the OB system in the early 1980s\. We did create a record\. One interesting problem was "ghost" pregnancies in which it appeared for a period of time to have two fetuses later to be one\. Our actually execution turned out to not create the new baby record until birth but to back load the data from the mother\. This also solved IDing problems\. Ed Hammond --- ## Post #19 by @system Genetic make\-up is only one possible distinctive feature\. We all know that even in human health care we can encounter twins, triples, etc that were cloned in a test tube and implanted in utero of a woman\. What sets them aside? I fear it is the administrative name that they receive in the end after a delivery\. Until then 'who knows who' in the womb of a pregnant woman? We must accept that we treat things without a name but with a more or less distinctive context or other features than an administrative name\. Gerard > I think that the only systematic approach is to make a new EHR for each > genetically distinct individual\. This means making an EHR for a foetus > as soon as anything at all is to be measured about it, and also storing > the link of this EHR to that of the mother\. If the foetus dies in utero > or is aborted, then its EHR shows this properly as "death" jsut as it > would be shown in a normal person's record\. As for situations where the > individual's DNA distinctness is not totally clear like the bone marro > transplant situation, I don't think that is a problem\. Observations can > be made on genetically different material to the patient, in the > patient's record, as long as these observations relate to the care of > that patient\. E\.g\. blood tests, other tests made to a sibling for the > sole purpose of doing a transplant into the patient \- should probably go > into the patient's EHR\.\.\. > > But I do think we need to forget the idea that because a foetus is not > really a person, it is not a possible subject of an EHR\. I think we have > to work on genetic distinction and distinct organism \(whether called > "human" or not\) instead\. > > thoughts? > > \- thomas > > Sam Heard wrote: > >> Matthew >> >> Great scenario's >> >>> 1\. If prenatal diagnosis is being done by chorionic villus sampling >>> \(CVS\) in a twin pregnancy \(which does happen\) then it is the placenta >>> \- or rather the placentas \- which are sampled\. Each placenta has a >>> DNA genotype matching that of the fetus attached to it \(ie not the >>> mother\) as the placenta is an extension of the fetus\. If however the >>> fetus is an extension of the mother, then are we really saying we >>> like the idea that the placentas may have to appear as multiple >>> "temporary" organs of the mother, which are different in every >>> pregnancy, and which never share her total genotype? A likely outcome >>> would be selective termination of one twin \(the affected one, on the >>> basis of a molecular finding and either a makable or a confidently >>> predictable clinical diagnosis\) leaving the unaffected one to go to >>> term\. Thus a part of the mother is diagnosed clinically and >>> molecularly, findings which are important for the mother later on, in >>> that they'll trigger appropriate care next time around, but which >>> \*must not\* be confused with her own clinical diagnoses or test >>> results\. >>> >> This example is a very good one \- it shows that there is a need to > > identify >> the fetus over and above its relationship with the mother\. I have > > suggested >> that we use a local label for this \- could be LOCAL:Twin1\_2002\. \- the >> relationship for the information is FETUS\. The important thing here is > > that >> we have the idea of subject of care \- a unique identifier \(or self\) > > and the >> relationship\. >> >> The sampling is the taking of a histological sample of a body part \- the >> subject is the FETUS\. There will be a procedure record, a sample and a >> histological report \- all with the fetus as the subject of care for the >> data \- in a composition that is part of the mothers EHR\. It may be > > copied to >> the child's EHR in the future \- I have thought about the transform > > required >> to do this and it should be relatively easy if the relationship of the two >> records is stated first\. >> >>> 2\. Bone marrow transplantation, where it may be necessary to >>> distinguish that the post\-transplant patient may still have a >>> haemoglobin variant, but a different one to the one they were treated >>> for, and accordingly no disorder to go with it, but will still be >>> genetically as they were before the treatment in every other organ\. >>> Also the donor was most probably selected from the same family, so >>> confidentiality may be slightly different\.\.\.? >>> >> Interesting \- who is the subject of care then? I guess this will be > > deduced >> from the data \- I do not think that we can say the origins of all the > > states >> in a person that arise following a donation \- at times it may be ambiguous >> \(graft v host\)\. >> >> We have considered 'donor' to be the relationship \- but the person may > > have >> a relationship with the person apart from this? I do not think that the >> subject of care needs to be the donor then \- it can be the family > > member as >> it is known who they are\. Interesting\! >> >>> It seems to me that we can either organise our concepts to make this >>> kind of record easier and more obvious, or we can begin to inbuild >>> problems for later on \(eg if the fetus is part of the mother, having >>> to explain to all our knowledge agents that this might not extend to >>> genotypes, or if it does, then by chance rather than biological >>> imperative etc\.\.\.\)\. In the event of one of two fetuses being >>> affected, and one pregnancy being terminated, what is the result in >>> the record to indicate the original number of conceptions, the fact >>> that a genetic risk actually produced a fetus with a prospective >>> problem, and the DNA and other data originated in the process of the >>> testing of the CVS sample? It would be wrong, I feel, to treat the >>> fetus' diagnosis as one of the mother, as confusion here could lead >>> to all kinds of erroneous conclusions \(one fetus had sickle cell \-> >>> mother \- who is actually just a carrier \- has sickle cell\.\.\.?\)\. >>> >> I do believe that we have this covered \- the donor example is a bit of a >> mind bender but I think the subject of care and relationship provides the >> solution\. >> >> COmments? >> >> Cheers, Sam >> \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ >> Dr Sam Heard >> Ocean Informatics, openEHR >> Co\-Chair, EHR\-SIG, HL7 >> Chair EHR IT\-14\-2, Standards Australia >> Hon\. Senior Research Fellow, UCL, London >> >> 105 Rapid Creek Rd >> Rapid Creek NT 0810 >> >> Ph: \+61 417 838 808 >> >> sam\.heard@bigpond\.com >> >> www\.openEHR\.org >> www\.HL7\.org >> \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ >> >> \- >> If you have any questions about using this list, >> please send a message to d\.lloyd@openehr\.org >> \-\- <private> \-\- Gerard Freriks, arts Huigsloterdijk 378 2158 LR Buitenkaag The Netherlands \+31 252 544896 \+31 654 792800 --- ## Post #20 by @Sam Dear All Sorry, I have been out of touch over the Xmas \- great surf on the east coast\! This may be old ground? This conversation is sounding a little like a technical solution rather than a pragmatic solution\. My response is that both solutions are required \- a fetal record \(rare\) and fetal recordings in the maternal record\. The fetal heart rate is an example of a measurement that is NOT the mother that is appropriate for the maternal record \- and I do not think that anyone is going to start a fetal record for this value\. Philippe is right \- fetal scans will sometimes \(rarely\) have implications for the future child and will need to be copied to that record in the future\. I do not think that linking between records will be an acceptable approach \- although it is attractive technically \- as it will pose a lot of privacy issues that the public are not ready for at this stage \- neither am I frankly\! Applications can clearly link the records as they wish with the appropriate access controls\. The scenario of not having family history records but rather a set of links to all relatives records is not tenable in the current environment and should not be proposed as a solution at this stage\. The fact that openEHR would allow this technically is not a problem\. I will read on in this thread\.\.\.\.Sam --- ## Post #21 by @Sam Ed Thanks for that \- I think this is the correct approach \- recognising that there will be times when a fetal record may be required \- such as with antenatal surgery etc\. Any thoughts on the EHR SIG? Cheers, Sam --- ## Post #22 by @Sam Dear All > 1\. In the demographic server, we create 2 PERSONs, and use a foetus > archetype for one\. We put a mother/in utero PARTY\_RELATIONSHIP > between them\. > > however, the in utero relationship as a clinical phenomenon is probably > more important than the legal mother/child relationship, which is the > kind of thing demographic systems are designed for \(this relationship > does not change as long as both parties are alive, but the carrying/in > utero physical relationship is fairly temporary\. For all sorts of reasons one cannot separate the mother and fetus until quite late in pregnancy \- many tests have implications for the fetus and for the mother and her pregnancy\. > 2\. In the EHR system we use an archetype for a persistent transaction in > the foetus's EHR which indicates the "in utero" situation \(this would > probably be the same archetype that carries other important clinical > indicators, like "living", "deceased" etc\)\. In the mother's EHR there is > also a "carrying child" indicator\. I am not sure about this \- I think this is getting far too complicated for what is a relatively simple situation and the reason why we had subject of care as a concept \(along with family history and donation\)\. > 2a\. THese could refer to distinct demographic entities found in the > demographic server, if we think that the foetus should be given one\. This goes against legal views as well as common practice and I think is the thin end of a large wedge that I would not like to see the EHR caught up in \- the human status of a fetus \- beware\! > If > not \(and I agree that it might not be that useful, since there is no > name, contact address etc \(other than the mother\) and the foetus is not > "contactable" in any real way \- in fact it cannot act as a PARTY \(i\.e\. > participate in anything\)\. So \- let's say that the foetus either has > nothing in the demographic system, or else we introduce a special party > called "unborn foetus" \(the same thing I suggest for "anonymous donor"\)\. Don't forget there can be up to 8\! > Then the Foetus can have a demographic entity to which its EHR is > attached, without the needless creation of "real" PARTYs with all their > details, all initially meaningless for a foetus \(and probabl a newborn > for quite some time\.\.\.\)\. > > The alternative which I imagine Sam would prefer is to make one or more > transactions dedicated to the foetus in the mother's EHR and put them in > their own "unborn child" folder or so\. It does not have to be the transaction \- a scan of the uterus is a good example \- much of the information is about the mother \- but the length of the femur and abdominal circumference is clearly about the fetus and needs to be identified as such\. Such a scan might then be copied to the child's EHR at some future date with a transform from 'fetus' to 'self' and from 'self' to 'mother'\. > These would then be moved out of > the mother's EHR when the baby is born\. No \- they would be copied if appropriate \- they are clearly related to the pregnancy and would stay there\. > I think this would work ok, but > it is kind of a special case, and we have to make sure all software > understands it\. Maybe we could formalise this situation so that one EHR > can "give birth" to another, which is implied by Matthew's words\. It > sounds funny, but maybe it isn't \- why not \- there is nothing to stop us > from defining a "give birth" operation on the interface of the EHR > \(trekkies and unix\-heads will naturally insist that the operation be > called "spawn", and who would I be to argue\.\.\.\.?\-\)\. Quite a cute idea\. > The situation is not necessarily the same for anonymous donors, since no > care is being given to them \- they don't need their own EHR \- the > observations of the organs etc belong in the EHR or the recipient since > it is about his/her care, not the donors\. > > For non\-anonymous donors, then of course an EHR is needed \- the health > of both donor and recipient during kidney, bone marrow and other similar > operations, and afterward is important jsut as in the normal situation > of any individual\. > > I am happy to see this discussed further; in summary I suggest that the > basic possibilities are : > > a \- create a new EHR as soon as a foetus has any observation done on it, No > link it to an "unborn baby" demographic entity Will have some specific markers as there may be more than 1\. > b \- define the semantics of an EHR "being pregnant" with another nascent This will have to evolve to some extent with experience\. A Cardiotocogram is a good example \- where the contractions are of the mother's uterus and the heart rate is of the fetus\. But they are read together\. > EHR, and a "give birth to EHR"/"spawn EHR" operation to be carried out > when the real birth takes place\. \(The less fortunate outcomes for the > foetus could also make sense, as long as they have operations defined > for them, including "abort", "die naturally" etc\)\. These would stay in the mother's EHR \- no need to 'clean up' at all\. > Having thought of b\), and the possibility of one day seeing one EHR give > birth to another, I am quite taken with the possibility\.\.\.\.however, it > still creates the precedent that there are EHRs containing two \(or more\) > subjects of care\. That is why it is there\! Sam --- ## Post #23 by @system It is my belief that there will not be one good for all model of the demographics\. There are several points of view: medical perinatologist, \- genetical, \-peadiatrician, \- gynacologist, \- pharmacist, \-etc, phycological, sociological, legal, ethical, administrative, etc\. Each viewpoint will have different models for different contexts\. The consequence is that one RIM with one Demographics part will be to restrictive\. One RIM with several types of demographic models \(using Archetypes/Templates\) is the sensible way to think about it\. Gerard <private> \-\- Gerard Freriks, arts Huigsloterdijk 378 2158 LR Buitenkaag The Netherlands \+31 252 544896 \+31 654 792800 --- **Canonical:** https://discourse.openehr.org/t/subject-of-care/15696 **Original content:** https://discourse.openehr.org/t/subject-of-care/15696